02532nas a2200337   4500000000100000008004100001260003400042653005700076653002100133653002800154100001300182700001600195700001600211700001100227700001400238700001200252700001400264700001400278700001200292700001100304700001400315700001300329700001500342700001200357700001200369700001200381245011700393856024600510520141300756022002502169       2022                            d  bOxford University Press (OUP)10aPublic Health, Environmental and Occupational Health10aGeneral Medicine10aHealth (social science)1 aHamill L1 aTrotignon G1 aMackenzie C1 aHill B1 aPavluck A1 aYumba D1 aIsiyaku S1 aWilliam A1 aNyior A1 aIgbe M1 aAnyaike C1 aAkilah J1 aAgyemang D1 aMarfo B1 aDowns P1 aJones I00aNavigating the way to onchocerciasis elimination: the feasibility and cost of onchocerciasis elimination mapping  uhttps://scholar.google.com/scholar_url?url=https://academic.oup.com/inthealth/advance-article-pdf/doi/10.1093/inthealth/ihab083/42538554/ihab083.pdf&hl=en&sa=T&oi=ucasa&ct=ufr&ei=SeoUYseFPIevyAS61b4I&scisig=AAGBfm3kOUPCKxJ6dvoKVb49j-3C5QZZYw3 a<p>Background</p>

<p>Onchocerciasis is targeted for elimination of transmission by 2030 in at least 21 countries. To achieve this, recent and accurate data on the extent and intensity of onchocerciasis transmission are required. This will include mapping areas previously unassessed, or remapping of areas that were last visited as part surveys aiming to prevent blindness, not assess transmission in totality. There is near universal acceptance of the need to carry out these mapping reassessments, to achieve equitable and lasting elimination of onchocerciasis transmission. However, there is no consensus on how to conduct onchocerciasis elimination mapping (OEM), and little published data to inform policymakers and programme managers, including on cost.</p>

<p>Methods</p>

<p>Here, we summarise the methods and cost implications of conducting pilot OEM surveys in Ghana and Nigeria in 2018. We have included a breakdown of costs incurred overall, per person and per implementation unit in each country, as well as detailed analysis of the cost categories and the main cost drivers. Results The procurement and logistics of diagnostics accounted for more than one-third of the total cost, a significant cost driver.</p>

<p>Conclusions</p>

<p>This information will be valuable to policymakers and donors as they seek to prioritise onchocerciasis elimination and plan to complete OEM.</p>
  a1876-3413, 1876-3405